This whitepaper from GMO, authored by Rick Friedman, Catherine LeGraw, and John Thorndike, explores the evolution of value investing and presents GMO’s innovative approach.
• Value Investing Evolution: Traditional metrics fail to capture the true value of modern companies, emphasizing the need for forward-looking models.
• GMO Strategy: Combines fundamental research and quantitative analysis, using proprietary tools like GMO Book to assess companies' productive capital and intrinsic value.
• Opportunities: Deep value stocks trade at historically low valuations, offering significant upside potential through rebalancing and disciplined active management.
For detailed insights into GMO’s differentiated strategies and value investing framework, access the full report.
To read this article, you need a subscription to Investment Officer. If you don't have a subscription yet, click on 'Subscribe' to see the various subscription options.
